Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALIMERA SCIENCES INC | 3,177,842 | reported | 27 Apr 2010 | tx 8+3,956,570−3,642,999 |
| PDS Biotechnology Corp | 2,068,582 | reported | 06 Oct 2015 | tx 4+2,068,582−2,150,538 |
| Oruka Therapeutics, Inc. | 6,000 | reported | 30 Jan 2024 | tx 5+42,000 |
| Anacor Pharmaceuticals Inc | 0 | reported | 24 Jun 2016 | tx 58+5,874,078−9,026,631 |
| Trubion Pharmaceuticals, Inc | 0 | reported | 28 Oct 2010 | tx 21+1,885,132−3,712,583 |
| Avalanche Biotechnologies, Inc. | 0 | reported | 05 Aug 2014 | tx 3+2,365,471−1,965,471 |
| WORLD HEART CORP | 0 | reported | 02 Aug 2012 | tx 8+1,189,050−8,270,472 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jan 2024 | GRANT_AWARD | Oruka Therapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 15 Dec 2022 | GRANT_AWARD | Oruka Therapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 12 Jan 2021 | GRANT_AWARD | Oruka Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 01 Mar 2018 | GRANT_AWARD | Oruka Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 16 Feb 2017 | GRANT_AWARD | Oruka Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 33,886 | 99.25 USD | |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 15,000 | — | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 15,000 | — | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 4,096 | — | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 30,000 | — | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 15,000 | — | deriv |
| 24 Jun 2016 | OTHER | Anacor Pharmaceuticals Inc | 12,500 | — | deriv |
| 16 May 2016 | SALE | Anacor Pharmaceuticals Inc | 199,865 | 99.41 USD | |
| 16 May 2016 | SALE | Anacor Pharmaceuticals Inc | 72,385 | 98.93 USD | |
| 16 May 2016 | SALE | Anacor Pharmaceuticals Inc | 81,631 | 100.60 USD | |
| 14 Apr 2016 | CONVERSION | Anacor Pharmaceuticals Inc | 257,647 | 31.05 USD | |
| 14 Apr 2016 | CONVERSION | Anacor Pharmaceuticals Inc | — | 0.00 USD | deriv |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 102,760 | 70.33 USD | |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 99,981 | 71.44 USD | |
| 08 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 3,868 | 70.05 USD | |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 2,272 | 73.29 USD | |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 200 | 74.13 USD | |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 6,820 | 75.57 USD | |
| 08 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 400 | 71.40 USD | |
| 07 Apr 2016 | SALE | Anacor Pharmaceuticals Inc | 13,000 | 72.15 USD |
3 purchases reported after at least 12 months of silence — most recent on 06 Oct 2015.